福建消化道肿瘤患者氮-乙化酶多态性调查

陈华; 张祥福; 许东坡; 张一帆; 孙昌盛; 王志红

福建消化道肿瘤患者氮-乙化酶多态性调查

1. 福建医科大学预防医学系,350004;2. 福建医科大学附属协和医院;3. 福建医科大学附属第一医院

计量
- 文章访问数: 908
- HTML全文浏览量: 29
- PDF下载量: 303
出版历程
- 刊出日期: 1999-06-04

Study on the NAT Polymorphism smong Gastrointestinal Carcinoma Patients in Fujian

Department of Environmental Health, Fujian Medical University, Fuzhou 350004

摘要

摘要: 为探讨N-乙酰化酶(NAT)多态性与消化道肿瘤遗传易感性的关系，检测了70例消化道肿瘤患者(胃癌34例、大肠癌28例、肝癌8例)和107例非肿瘤对照的N-乙酰化酶多态表型。结果显示70例消化道肿瘤患者27例为慢型(38.57%)；107例对照20例为慢型(18.69%)，两者之间有显著差异。OR值为2.67(95%CI 1.28~5.61)，提示N-乙酰化酶表型慢型患消化道肿瘤的危险性增加1.67倍。本调研为深入探讨消化道肿瘤的病因学并加强预防提供了新的线。
- N－乙酰化酶多态 /
- 消化道肿瘤 /
- 病例对照研究
Abstract: In order to clarify the relationship between the polymorphism of N-Acetyltransferase (NAT) and genetic susceptibility to gastrointestinal Carcinoma. Phenotypy of NAT polymorphism was determined among 70 patients with gastrointestinal carcinoma (34 gastric cancer. 28 colerectal cancer and 8 primary liver cancer) and 107 health controls in Fujian. The results showed that the slow type of NAT was 38 57% (27/70) for cases, and 18 69% (20/107) for the controls. The difference between the cases and controls was statistically significant ( x²=8 15, P =0 0043).The odds ratio was 2 67 (95% CI 1 28～5 61), which suggest that persons with slow type NAT have 1 67 times of the increased risk of gastrointestinal carcinoma, This investigation would throw a new clue into the study of aetiology and prevention of gastrointesinal carcinoma.
- Polymorphism of N-Acetyltransferase /
- Gastrointestinal /
- CarcinomaCase-Control study